Kelly Bliss - 01 Oct 2024 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role: President, U.S. Group Health
Signature: /s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol: TDOC
Transactions as of: 01 Oct 2024
Net transactions value: -$7,783
Form type: 4
Filing time: 02 Oct 2024, 16:13:41 UTC
Previous filing: 27 Sep 2024
Next filing: 03 Dec 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TDOC	Common Stock	Options Exercise		+2,631	+9.9%		29,100	01 Oct 2024	Direct	F1
transaction	TDOC	Common Stock	Sale	$7,783	-897	-3.1%	$8.68	28,203	02 Oct 2024	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TDOC	Restricted Stock Units	Options Exercise	$0	-2,631	-100%	$0.000000	0	01 Oct 2024	Common Stock	2,631		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F2	Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
F3	On October 1, 2021, the reporting person was granted 7,892 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.